Venus Remedies Ltd — Meropenem Exporter Profile
Indian Pharmaceutical Exporter · #6 for Meropenem · $1.6M export value · DGFT Verified
Venus Remedies Ltd is the #6 Indian exporter of Meropenem with $1.6M in export value and 33 verified shipments. Venus Remedies Ltd holds a 0.9% market share in Meropenem exports across 10 countries.
Venus Remedies Ltd — Meropenem Export Profile: Buyers & Destinations
Where Does Venus Remedies Ltd Export Meropenem?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SAUDI ARABIA | $4.5M | 194 | 25.4% |
| GERMANY | $3.6M | 187 | 20.5% |
| PERU | $1.5M | 31 | 8.4% |
| AUSTRALIA | $1.1M | 25 | 6.1% |
| HUNGARY | $1.0M | 24 | 5.9% |
| MEXICO | $691.2K | 20 | 3.9% |
| BAHRAIN | $541.0K | 16 | 3.0% |
| SUDAN | $537.2K | 13 | 3.0% |
| SOUTH AFRICA | $403.7K | 13 | 2.3% |
| ISRAEL | $395.1K | 13 | 2.2% |
Venus Remedies Ltd exports Meropenem to 47 countries. The largest destination is SAUDI ARABIA accounting for 25.4% of Venus Remedies Ltd's Meropenem shipments, followed by GERMANY (20.5%) and PERU (8.4%). These destinations reflect Venus Remedies Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Meropenem from Venus Remedies Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| VENUS PHARMA GMBH | GERMANY | $2.3M | 144 |
| S T C | SAUDI ARABIA | $2.3M | 95 |
| SALEHIYA TRADING COMPANY | SAUDI ARABIA | $1.3M | 64 |
| E P H K | HUNGARY | $1.0M | 24 |
| S T C SALEHIYA TRADING | SAUDI ARABIA | $714.9K | 28 |
| VPG VENUS PHARMA GMBHAM BAHNHOF | GERMANY | $621.9K | 15 |
| G H | AUSTRALIA | $569.4K | 13 |
| V P G | GERMANY | $558.9K | 22 |
| O S.A.C. | PERU | $450.0K | 9 |
| SAMASU MEDICAL & EDUCATIONAL | SUDAN | $397.1K | 10 |
Venus Remedies Ltd supplies Meropenem to 154 buyers globally. The largest buyer is VENUS PHARMA GMBH (GERMANY), followed by S T C (SAUDI ARABIA) and SALEHIYA TRADING COMPANY (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Meropenem Export Value and How Much Does Venus Remedies Ltd Contribute?
India exported $80.5M worth of Meropenem through 3,658 shipments from 401 suppliers to 134 countries, serving 966 buyers globally. Venus Remedies Ltd contributes $1.6M to this total, accounting for 0.9% of India's Meropenem exports. Venus Remedies Ltd ships Meropenem to 47 countries through 154 buyers.
What Is the Average Shipment Value for Venus Remedies Ltd's Meropenem Exports?
Venus Remedies Ltd's average Meropenem shipment value is $50.0K per consignment, based on 33 shipments totaling $1.6M. The largest destination is SAUDI ARABIA (25.4% of Venus Remedies Ltd's Meropenem exports).
How Does Venus Remedies Ltd Compare to Other Indian Meropenem Exporters?
Venus Remedies Ltd ranks #6 among 401 Indian Meropenem exporters with a 0.9% market share. The top 3 exporters are VENUS REMEDIES LIMITED ($40.0M), EUGIA PHARMA SPECIALITIES LIMITED ($17.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.3M). Venus Remedies Ltd processed 33 shipments to 10 destination countries.
What Meropenem Formulations Does Venus Remedies Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MEROPENEM 1.0 GM POWDER FOR SOLUTION FOR | $3.1M | 111 |
| MEROPENEM 500 MG POWDER FOR SOLUTION FOR | $1.7M | 56 |
| MEROPENEM 1.0GM POWDER FOR SOLUTION FOR | $409.5K | 10 |
| RONEM 500 MG (MEROPENEM POWDER FOR SOLUTION FOR INJECTION) MOOWR SCHEME VIDE LICENSE NO.- 03/2023 -LUDHIANANOS | $300.0K | 6 |
| MEROPENEM 1.0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSION (RONEM 1000 MG) | $212.5K | 10 |
| MEROPENEM 1 0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSION RONEM 1000 MG | $195.4K | 10 |
| MEROPENEM 1.0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSION (MEROPENEM VENUSPHARMA 1 GM) | $150.0K | 3 |
| MEROPENEM 1.0 GM POWDER FOR SOLUTION FORINJECTION OR INFUSION MEROPENEM VENUSPHARMA 1.0 GM | $150.0K | 3 |
| MEROPENEM GH 1000 MG MEROPENEM (AS TRIHYDRATE) 1000 MG POWDER FOR INJECTION 1VIAL CONTAINS: MEROPENEM (AS TRIHYDRATE)NOS | $150.0K | 3 |
| RONEM 1000 MG (MEROPENEM 1 G POWDER FORSOLUTION FOR INJECTION OR INFUSION) (MOOWR SCHEME VIDE LICENSE NO.-03/2023 -LDH)NOS | $150.0K | 3 |
Venus Remedies Ltd exports 441 distinct Meropenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEROPENEM 1.0 GM POWDER FOR SOLUTION FOR with 111 shipments worth $3.1M.
Regulatory Requirements: Exporting Meropenem to Key Markets
What Venus Remedies Ltd must comply with to export Meropenem to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Venus Remedies Ltd Compare to Nearest Meropenem Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | BROOKS STERISCIENCE LIMITED | $2.3M | 45 | 9 | $50.0K |
| 10 | SWISS PARENTERALS LIMITED | $2.0M | 46 | 14 | $43.1K |
| 6 | VENUS REMEDIES LTD ★ | $1.6M | 33 | 10 | $50.0K |
| 9 | GLAND PHARMA LIMITED | $1.6M | 33 | 2 | $50.0K |
| 11 | M. J. BIOPHARM PRIVATE LIMITED | $1.4M | 45 | 9 | $32.1K |
Venus Remedies Ltd ranks #6 among 401 Indian Meropenem exporters. Average shipment value of $50.0K compared to the market average of $200.8K. The closest competitors by value are BROOKS STERISCIENCE LIMITED and SWISS PARENTERALS LIMITED.
Which Indian Ports Ship Meropenem Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 504 | 13.8% |
| DELHI AIR | 494 | 13.5% |
| SAHAR AIR | 256 | 7.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 246 | 6.7% |
| NHAVA SHEVA SEA (INNSA1) | 233 | 6.4% |
| CMA CGM LOGISTICS PARK ICD (INCPL6) | 198 | 5.4% |
| Delhi Air | 103 | 2.8% |
| DHANNAD ICD (INDHA6) | 94 | 2.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Meropenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Meropenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Venus Remedies Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 834 individual customs records matching Venus Remedies Ltd exporting Meropenem, covering 441 formulations to 47 countries via 154 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 134+ countries, 966+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Meropenem Export Data from Venus Remedies Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Venus Remedies Ltd's Meropenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Venus Remedies Ltd
Company Profile
0 products · $0 total trade · 0 categories
Meropenem Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Venus Remedies Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Meropenem. For current shipment-level data, contact TransData Nexus.